Schnee Elmar 4
4 · Jazz Pharmaceuticals plc · Filed Aug 13, 2018
Insider Transaction Report
Form 4
Schnee Elmar
Director
Transactions
- Award
Ordinary Shares
2018-08-09+1,495→ 6,836 total - Sale
Ordinary Shares
2018-08-10$176.61/sh−742$131,045→ 6,094 total - Award
Non-Qualified Stock Option (right to buy)
2018-08-09+3,735→ 3,735 totalExercise: $177.73Exp: 2028-08-08→ Ordinary Shares (3,735 underlying)
Footnotes (4)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.61 to $176.872, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018.